Melanoma early detection and awareness: how countries developing melanoma awareness programs could benefit from melanoma-proficient countries

- Wainstein, Alberto, Algarra, Salvador Martin, Whitaker, Dagmar, Quirt, Ian, Hauschild, Axel, Rutkowski, Piotr, Bastholt, Lars, Cinat, Gabriela, Demidov, Lev, Grob, Jean Jacques, Guo, Jun, Hersey, Peter, Espinosa, Enrique, Schachter, Jacob

Side effects and toxicities of targeted therapies in stage IV melanoma

- Ascierto, Paolo A., Bastholt, Lars, Hersey, Peter, Cinat, Gabriela, Eggermont, Alexander M. M., Hauschild, Axel, Espinosa, Enrique, Robert, Caroline

Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma

- Kirkwood, John M., Lorigan, Paul, Hersey, Peter, Hauschild, Axel, Robert, Caroline, McDermott, David, Marshall, Margaret A., Gomez-Navarro, Jesus, Liang, Jane Q., Bulanhagui, Cecile A.

Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with Carboplatin and Paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma

- Hauschild, Axel, Agarwala, Sanjiv S, Peschel, Christian, Schadendorf, Dirk, Garbe, Claus, O'Day, Steven, Daud, Adil, White, J. Michael, Xia, Chenghua, Patel, Kiran, Kirkwood, John M., Keilholz, Ulrich, Trefzer, Uwe, Hogg, David, Robert, Caroline, Hersey, Peter, Eggermont, Alexander, Grabbe, Stephan, Gonzalez, Rene, Gille, Jens